MapLight Therapeutics, Inc. <MPLT.O>: H.C. Wainwright cuts target price to $26 from $45
MPLT•Related News
Skippy peanut butter maker Hormel Foods names insider John Ghingo as CEO
HRL•
S&P Global Q2 GAAP diluted EPS rises 18% to $4.12; GAAP revenue increases 10% to $4.15 billion
SPGI•
XPLR Infrastructure Q2 FY26 net income falls 51.9% to $38 million; revenue rises 6.1% to $363 million
XIFR•
SouthState Bank Corp <SSB.N>: Truist Securities raises target price to $118 from $108
SSB•
Core Scientific signs AI infrastructure deal with AMD
CORZ•